Kennedy Capital Management’s Emergent Biosolutions EBS Stock Holding History

Kennedy Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-220,683	Closed	-$4.63M	–	618
2022 Q3	$4.63M	Buy	+220,683	New	+$4.63M	0.14%	270
2021 Q2	–	Sell	-12,661	Closed	-$1.18M	–	638
2021 Q1	$1.18M	Sell	12,661 -35,078	-73%	-$3.26M	0.02%	542
2020 Q4	$4.28M	Buy	47,739 +30,014	+169%	+$2.69M	0.1%	382
2020 Q3	$1.83M	Sell	17,725 -28,011	-61%	-$2.9M	0.05%	494
2020 Q2	$3.62M	Buy	45,736 +7,792	+21%	+$616K	0.1%	370
2020 Q1	$2.2M	Buy	37,944 +1,187	+3%	+$68.7K	0.08%	435
2019 Q4	$1.98M	Sell	36,757 -49,766	-58%	-$2.68M	0.05%	547
2019 Q3	$4.52M	Sell	86,523 -1,510	-2%	-$78.9K	0.11%	351
2019 Q2	$4.25M	Sell	88,033 -2,698	-3%	-$130K	0.1%	369
2019 Q1	$4.58M	Sell	90,731 -4,182	-4%	-$211K	0.11%	353
2018 Q4	$5.63M	Sell	94,913 -57,682	-38%	-$3.42M	0.14%	277
2018 Q3	$10M	Sell	152,595 -18,356	-11%	-$1.21M	0.19%	179
2018 Q2	$8.63M	Sell	170,951 -11,703	-6%	-$591K	0.16%	213
2018 Q1	$9.62M	Sell	182,654 -41,347	-18%	-$2.18M	0.19%	162
2017 Q4	$10.4M	Sell	224,001 -9,541	-4%	-$443K	0.19%	165
2017 Q3	$9.45M	Buy	233,542 +154,073	+194%	+$6.23M	0.17%	189
2017 Q2	$2.7M	Sell	79,469 -85,144	-52%	-$2.89M	0.05%	541
2017 Q1	$4.78M	Sell	164,613 -12,454	-7%	-$362K	0.08%	431
2016 Q4	$5.82M	Sell	177,067 -3,944	-2%	-$130K	0.1%	352
2016 Q3	$5.71M	Buy	181,011 +1,224	+0.7%	+$38.6K	0.11%	329
2016 Q2	$5.06M	Buy	179,787 +85,978	+92%	+$2.42M	0.1%	343
2016 Q1	$3.41M	Sell	93,809 -59,915	-39%	-$2.18M	0.07%	466
2015 Q4	$6.15M	Sell	153,724 -100,847	-40%	-$4.03M	0.12%	300
2015 Q3	$7.25M	Sell	254,571 -67,851	-21%	-$1.93M	0.15%	247
2015 Q2	$10.6M	Sell	322,422 -11,687	-3%	-$385K	0.19%	167
2015 Q1	$9.61M	Sell	334,109 -13,394	-4%	-$385K	0.17%	204
2014 Q4	$9.46M	Buy	347,503 +85,347	+33%	+$2.32M	0.17%	201
2014 Q3	$5.59M	Buy	+262,156	New	+$5.59M	0.11%	340